Literature DB >> 11525561

Gene delivery of vaccines for infectious disease.

K R Clark1, P R Johnson.   

Abstract

Genetic immunization is the process of delivering and expressing a gene (or therapeutic nucleic acid) encoding a pathogen-derived antigen into target host cells to elicit a protective humoral or cell-mediated immune response. Gene delivery methods to achieve this goal have expanded rapidly, and currently employ a variety of oligonucleotides, synthetic polypeptides, recombinant vectors and even edible plants, all of which have been shown to be capable of inducing protective immunity in experimental animal models. This review highlights recent progress in several gene delivery systems (both non-viral and viral methods) using novel in vivo approaches to engender effective host immune responses against the introduced antigen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525561

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  8 in total

1.  Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Authors:  Lennart Holterman; Ronald Vogels; Remko van der Vlugt; Martijn Sieuwerts; Jos Grimbergen; Jorn Kaspers; Eric Geelen; Esmeralda van der Helm; Angelique Lemckert; Gert Gillissen; Sandra Verhaagh; Jerome Custers; David Zuijdgeest; Ben Berkhout; Margreet Bakker; Paul Quax; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.

Authors:  Philip R Johnson; Bruce C Schnepp; Mary J Connell; Daniela Rohne; Suzanne Robinson; Georgia R Krivulka; Carol I Lord; Rebekah Zinn; David C Montefiori; Norman L Letvin; K Reed Clark
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia.

Authors:  Hongxia Cai; Zhihao Mu; Zhen Jiang; Yongting Wang; Guo-Yuan Yang; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2015-05-15       Impact factor: 5.203

4.  High-efficiency system for the construction of adenovirus vectors and its application to the generation of representative adenovirus-based cDNA expression libraries.

Authors:  Moritz Hillgenberg; Christian Hofmann; Herbert Stadler; Peter Löser
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.

Authors:  Andrew T Catanzaro; Richard A Koup; Mario Roederer; Robert T Bailer; Mary E Enama; Zoe Moodie; Lin Gu; Julie E Martin; Laura Novik; Bimal K Chakrabarti; Bryan T Butman; Jason G D Gall; C Richter King; Charla A Andrews; Rebecca Sheets; Phillip L Gomez; John R Mascola; Gary J Nabel; Barney S Graham
Journal:  J Infect Dis       Date:  2006-11-08       Impact factor: 5.226

6.  Long-term storage of DNA-free RNA for use in vaccine studies.

Authors:  Kathryn L Jones; Debbie Drane; Eric J Gowans
Journal:  Biotechniques       Date:  2007-11       Impact factor: 1.993

7.  Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.

Authors:  Jennifer Schepp-Berglind; Min Luo; Danher Wang; Jason A Wicker; Nicholas U Raja; Brian D Hoel; David H Holman; Alan D T Barrett; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

8.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.